Objective: Cardiac preconditioning represents an important cardioprotective mechanism which limits myocardial ischaemic damage. The aim of this investigation was to assess the impact of preconditioning in hypertension, which is a major risk factor for ischaemic heart ŽŽ . . Ž . disease. Methods: Hearts isolated from male transgenic mREN-2 27 hypertensive TGH rats, and their normotensive controls Ž . Hannover Sprague-Dawley; SD rats , were perfused at constant flow using the Langendorff technique, and were subjected to either Ž . ischaemic preconditioning 3 = 4 min ischaemia or continuous perfusion. Global ischaemia was then induced for 30 min, followed by 60 Ž Ž . min of reperfusion, during which time mechanical performance was assessed left ventricular developed pressure LVDP , heart rate, and . end-diastolic pressure . Results: In the absence of preconditioning, mechanical performance was substantially depressed on reperfusion, Ž Ž . Ž . and there was no difference between TGH hearts and SD hearts area under the curve AUC for the LVDP LVDP plot against time 0 -60 . for reperfusion s 356 " 115 and 296 " 206 mmHgP min, respectively . Cardiac preconditioning caused significant protection in both Ž . Ž . Ž . groups, but this was significantly P -0.05 greater 3-fold in the TGH hearts AUC for LVDP s 3349 " 610 mmHgP min 0 -60 Ž . compared to the SD hearts AUC for LVDP s 1153 " 527 mmHgP min . In both groups, preconditioning induced significant 0 -60 protection of diastolic function. The enhanced effects of preconditioning on mechanical performance in the TGH hearts were unaffected Ž . by the angiotensin AT -receptor antagonist, losartan 3 mM . However, losartan did partially reverse the beneficial effects of 1 preconditioning on post-ischaemic diastolic function in the TGH hearts. Conclusions: The results of the present investigation clearly show that cardiac preconditioning is substantially enhanced in hearts from TGH rats. Furthermore, the beneficial effects of preconditioning on diastolic function, but not mechanical performance, in TGH hearts is partially mediated by AT -receptors. 
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Introduction
Brief periods of transient cardiac ischaemia exert a protective effect on the myocardium, by limiting both ischaemic tissue damage and arrhythmogenesis, following prolonged ischaemia. This phenomenon has been termed w x 'cardiac preconditioning' 1 , and protects the heart in all w x species so far studied, including man 2-4 .
The mechanisms underlying cardiac preconditioning have been extensively investigated, and several regulatory systems have been implicated in different species. For example, it is known that adenosine may cause protection ( )of cardiac preconditioning, ischaemic damage has been shown to be enhanced in various models of hypertension. In this respect, hearts from rats rendered hypertensive w x through chronic nitric oxide inhibition 8 , and hearts from w x spontaneously hypertensive rats 9 , show an increased incidence of arrhythmias on reperfusion after ischaemia, which is related to the degree of left ventricular hypertrow x phy 9 . Furthermore, in the canine heart, the infarct size on coronary occlusion has been reported to be greater in w x hypertensive than in normotensive animals 10 . However, this phenomenon was unrelated to left ventricular hypertrow x phy, but was linked to elevated arterial pressure 11 . To our knowledge only two investigations have so far examined the effects of hypertension on preconditioning. In the w x first, Speechly-Dick et al. 12 found that the hypertrophied myocardium of rats with mineralocorticoid-induced hypertension was protected by preconditioning in vivo. More w x recently, Boutros and Wang 13 reported that, in hearts Ž . isolated from spontaneously hypertensive rats SHR , preconditioning induced significant protection of mechanical performance, but to a slightly lesser degree than that in hearts from normotensive controls.
We have now investigated the effects of cardiac preconditioning, ex vivo, using hearts from male, heterozygous, ŽŽ . . Ž . transgenic mREN-2 27 hypertensive TGH rats, with Ž . Hannover Sprague-Dawley SD rats as the appropriate w x normotensive controls 14-17 . Heterozygous TGH rats have substantial elevations in systemic arterial pressure, w x and have associated cardiovascular changes 14-17 , including left ventricular hypertrophy. In the present investigation, all the hearts were perfused and reperfused at constant flow, in order to eliminate complications due to impairment of the reactive hyperaemic response, which contributes to reduced post-ischaemic recovery in the hyw x pertrophied myocardium 18 . Furthermore, the hearts were all perfused at matched flow rates, as there is evidence that coronary flow is similar in normotensive and hypertensive rats, despite the presence of myocardial hypertrophy in the w x latter 19 . In each case, the effects of preconditioning were assessed by both the recovery of mechanical performance on reperfusion and the changes in end-diastolic pressure.
The TGH rats studied in the present investigation were originally produced by insertion of the mouse renin-2 gene into the rat genome. These TGH rats have enhanced Ž . activity of local renin-angiotensin systems RASs w x 14,15,17,20 , which is thought to contribute to the cardiow x vascular changes, including cardiac hypertrophy 17,20,21 . Indeed, cardiac RAS has been implicated in other non-hyw x pertensive rat models of left ventricular hypertrophy 22 .
w x In view of the elevated intracardiac RAS in TGH rats 20 , the effects on preconditioning of the selective angiotensin AT -receptor antagonist, losartan, were investigated. This 1 was of particular interest, since recent evidence from isolated perfused rabbits hearts has shown that treatment with angiotensin II, prior to an ischaemic insult, may mimic cardiac preconditioning, and this effect is mediated via w x AT -receptor-dependent activation of protein kinase C 23 . . tralinstitut fur Versuchstierkunde, Hannover were studied. The heterozygous TGH rats were bred by crossing male, homozygous TGH rats with female, control SD rats. The homozygous TGH rats were kept on chronic captopril Ž y1 w x. treatment 50 mg P l in the drinking water 14 , but the heterozygous animals used in this study were untreated.
Methods

This investigation conformed to the
Measurement of arterial pressure in conscious rats
Ž
The rats were anaesthetized sodium methohexitone,
y1
. Brietal, Lilly, Basingstoke; 40-60 mg P kg i.p. and had polyethylene catheters implanted in the abdominal aorta Ž . via the caudal artery , for blood pressure and heart rate recording, and in the right jugular vein for the administra-Ž . tion of heparin and anaesthetic see below . At least 24 h later, measurements of mean arterial blood pressure and heart rate were made in fully conscious, freely moving Ž animals, using a Gould electrostatic recorder ES 1000 . with SP400 preamplifier , transducer amplifier and rate Ž . Ž meter Biotach model 13-4613-65A Gould Electronics, . Cleveland, OH, USA . . Ithaca, NY, USA coupled to an extracorporeal flow probe, placed in series with the aortic cannula. Coronary perfusion pressure was measured by means of a second pressure transducer connected to the aortic cannula and coupled to the recording system.
Preparation of the isolated
Experimental protocol
Following a 30 min equilibration period, baseline cardiac variables were recorded and the hearts were then w x either subjected to a preconditioning cycle 25 or were Ž . continuously perfused i.e., non-preconditioned . To induce preconditioning, perfusion was stopped for 4 min, while the heart was bathed in buffer at 378C, and the preparation was then reperfused for 6 min, after which the cycle was repeated twice more. At the end of the reperfusion phase of the third cycle, the hearts were subjected to 30 min of homeothermic global ischaemia, followed by 60 min of reperfusion. As recovery of cardiac function is w x optimized at reduced reperfusion flow rates 26 , the flow on reflow was, in all cases, reduced to 75% of the initial Ž y1 . pre-ischaemic flow i.e., 15 ml P min ; throughout this time the cardiac variables were continuously monitored. The non-preconditioned hearts were treated in a similar manner to the preconditioned hearts, except that, instead of the 3 cycles of preconditioning, the hearts were perfused continuously for 30 min immediately prior to the ischaemic insult.
Some preparations were treated with the AT -receptor 1 antagonist, losartan, which was added to the perfusion fluid to achieve a concentration of 3 mM, and was present throughout the experiment. This concentration of losartan was found, in preliminary experiments, to completely abol-Ž ish the increases in coronary perfusion pressure F 10 . mmHg produced by bolus administration of angiotensin II Ž . 5-500 pmol . In the isolated perfused rabbit heart a similar concentration was found to abolish the cardioprow x tective effects of angiotensin II 23 .
Quantitation and statistical analysis
All data are given as the mean " s.e.m. and baseline variables were compared by Mann-Whitney U-tests. Cardiac mechanical performance was quantified as the rate = Ž pressure product RPP, the mathematical product of LVDP . and HR . Diastolic function was assessed as the end-di-Ž . astolic pressure. The areas under the curves AUCs for the LVDP-, HR-and EDP-time plots were determined, by means of KaleidaGraph, in order to give a quantitative measure of the magnitude of the recoveries of cardiac performance during the 60 min reperfusion period. The derived AUCs were then compared using the Kruskal-Wallis test with significance being determined by Dunn's post-test.
Drugs
Ž Losartan, a generous gift from Dr. R.D. Smith Merck . Sharp and Dohme, USA was initially dissolved as a stock Ž . solution in 0.9% wrv saline prior to addition to the perfusion fluid.
Results
Baseline cardioÕascular Õariables
In conscious, unrestrained TGH rats, the mean arterial Ž . Ž . pressure MAP was 160 " 5 mmHg n s 12 , which was Ž . significantly P -0.001 higher than in age-matched nor-Ž . motensive SD rats 108 " 4 mmHg, n s 11 . The cardiac Ž . mass to body mass ratio was also significantly P -0.001 higher in the TGH rats with a value of 0.55 " 0.01 g P 100 y1 Ž . g body weight n s 26 compared with a value of y1 Ž . 0.41 " 0.01 g P 100 g bw n s 22 in the SD rats.
Baseline cardiac Õariables
In hearts perfused at constant flow there were no significant differences between baseline coronary perfusion pres-Ž . sure, developed left ventricular pressure LVDP , or the Ž . rate = pressure product RPP of the hearts from the hyper-Ž tensive rats and those from their appropriate controls Ta-. Ž . ble 1 . There was, however, significant P -0.01 bradycardia in the hearts from TGH rats compared to those from Ž . the SD normotensive controls Table 1 .
In the case of the SD and TGH hearts treated with 3 mM losartan there were no significant differences in either baseline mechanical performance or coronary perfusion pressure compared to preparations not receiving the antag-Ž . onist Table 1 .
RecoÕery of mechanical performance on reperfusion following 30 min of global ischaemia in the SD hearts
Following the 30 min ischaemic period, the recovery of mechanical performance on reperfusion in the SD hearts was substantially greater in the preconditioned, compared Ž . to the non-preconditioned, preparations Fig. 1 . Specifi- Table 1 shows the cardiac variables LVDP s left ventricular developed pressure; HR s heart rate; RPP s rate=pressure product; CPP s coronary . perfusion pressure prior to the preconditioning or continuous perfusion in hearts from the SD and TGH rats. PC indicates the preconditioned groups and non-PC the non-preconditioned groups. The data are mean"s.e.m. ) P -0.05, ) ) P -0.01: significant differences compared to the appropriate normotensive control.
Ž
. cally, the area under the curve AUC for LVDP-time plot Ž . between 0 and 60 min of reperfusion LVDP was 0 -60 Ž . significantly P -0.001 greater in the preconditioned than Ž . in the non-preconditioned hearts Fig. 1a ; Table 2 . The Ž . recovery of HR was also significantly P -0.05 greater in the preconditioned hearts than in the non-preconditioned Ž . hearts Fig. 1b ; Table 2 . Accordingly, the recovery of the Ž . RPP at 60 min RPP of reperfusion was 6046 " 2025 ts60 mmHgP beats P min y1 in preconditioned hearts, which was Ž . significantly P -0.05 greater than in the non-precondi-Ž y1 . tioned hearts 891 " 693 mmHgP beats P min . In both cases, coronary perfusion pressure showed a significant Ž . Ž P-0.05 increase from baseline on reperfusion see Table  . 1 , but this did not differ between the preconditioned Ž . Ž 107 " 8 mmHg at 60 min and non-preconditioned 97.3 . " 10.8 mmHg at 60 min hearts.
RecoÕery of mechanical performance on reperfusion following 30 min of global ischaemia in the TGH hearts
Recovery of systolic function was also greater in preconditioned hearts from the TGH rats than in the non-pre-Ž . conditioned hearts Fig. 1 in that the AUC for LVDP 0 -60 Ž . in the preconditioned hearts was significantly P -0.001 greater than the corresponding value in the non-precondi-Ž . tioned group Fig. 1a ; Table 2 . The recovery of HR was Ž . also significantly P -0.05 greater in the preconditioned Ž hearts than in the non-preconditioned hearts Fig. 1b; . Table 2 . Accordingly, in the preconditioned hearts the RPP was 14 500 " 2 840 mmHgP beats P min y1 , which ts60 Ž . was significantly P -0.01 greater than the correspond-Ž ing value for the non-preconditioned TGH hearts 1659 " y1 . 816 mmHgP beats P min . In both cases, coronary perfu-Ž . sion pressure showed a significant P -0.05 increase on Ž . reperfusion above baseline see Table 1 which was slightly Ž higher in the non-preconditioned 147 " 12 mmHg at 60 . Ž min hearts than in the preconditioned 111 " 11 mmHg at . 60 min group.
The recovery of the mechanical performance in the preconditioned TGH hearts was substantially and signifi-Ž . cantly P -0.05 greater than in the preconditioned SD control hearts, such that the AUC of LVDP for the 0 -60 TGH hearts was 3-fold greater than that obtained for the Ž . SD hearts Fig. 1 ; Table 2 , and the LVDP was ts60 Ž . Ž significantly P -0.05 greater in the TGH 56.4 " 10. 4 . Ž . mmHg hearts than in the SD 22.8 " 7.9 mmHg hearts. Table 2 shows the AUC for the plots of the cardiac variables LVDP s left ventricular developed pressure; HR s heart rate; EDP s end-diastolic . Ž . Ž . pressure against time for the reperfusion period 0-60 min in hearts from the SD and TGH rats in the absence and presence of losartan 3 mM . PC s preconditioned groups; Non-PC s non-preconditioned groups. The data are mean"s.e.m. ) P -0.05, ) ) P -0.01, ) ) ) P -0.001: significant differences between the preconditioned hearts and non-preconditioned controls.
q P -0.05: significant differences between the normotensive and hypertensive groups for the different treatments.
§ P -0.05: significant differences between the absence and presence of losartan for the preconditioned hearts.
( )The difference in recovery was less marked for the heart rates, with there being a less than 2-fold enhancement in Ž . AUC for TGH compared to SD P -0.05 . However, there was no significant difference between the heart rates Ž after 60 min of reperfusion TGH s 259 " 14 beats P y1 y1 . min ; SD s 217 " 42 beats P min .
Despite the marked differences in recovery of mechanical performance in the preconditioned hearts between the hypertensive and the normotensive groups, there were no differences between the non-preconditioned TGH and SD Ž . hearts Fig. 1 . 
Effect of losartan on post-ischaemic recoÕery in the preconditioned SD and TGH hearts
The recovery of the preconditioned SD hearts in the presence of losartan was similar to that reported above, in Ž . the absence of the antagonist Fig. 2 ; Table 2 . At the end Ž . Fig. 1 . Recovery of mechanical performance a, left ventricular pressure, LVDP; b, heart rate in preconditioned and non-preconditioned SD and TGH rat hearts. In each case, the baseline values are given before and after the preconditioning cycle, prior to 30 min of global ischaemia. R indicates reperfusion Ž . after the ischaemic period and the time indicates the minutes after reflow. B s data from the SD hearts subject to preconditioning ns 7 and I s data Ž . Ž . from the non-preconditioned experiments ns 7 . In the case of the TGH hearts, the results in the preconditioned group are indicated by v; ns11 and Ž . Ž . the data from the non-preconditioned experiments ns 7 are shown by`. The values for the AUCs are given in Table 2 . The data are given as mean"s.e.m. with the vertical lines indicating the errors.
( )of reperfusion, coronary perfusion pressure was 99.2 " 14.2 mmHg and was not different from the comparable value in Ž . the absence of the drug given above . In the preconditioned TGH hearts, the recovery of cardiac performance in the presence of losartan was not significantly different Ž from that observed in the absence of the drug Fig. 3; . Table 2 . The coronary perfusion pressure was 113 " 17 mmHg and not different from the comparable value in the Ž . absence of the drug given above .
Changes in end-diastolic pressure during ischaemia and on reperfusion
In all hearts studied, Fig. 3 shows that there were significant increases in intraventricular pressure at the end of the global ischaemia and immediately prior to reperfu-Ž . sion a phenomenon known as the 'ischaemic contracture' , which were greater in the non-preconditioned than in the preconditioned preparations. The intraventricular pressures Ž . Fig. 2 . Recovery of mechanical performance a, left ventricular pressure, LVDP; b, heart rate in preconditioned SD and TGH rat hearts in the absence and presence of 3 mM losartan. The baseline values are given before and after the preconditioning cycle, prior to 30 min of global ischaemia. R indicates Ž . reperfusion after the ischaemic period and the time shows the minutes after reflow. B s data from the SD hearts in the absence of losartan ns 7 and v Ž . Ž . s data from TGH hearts in the absence of losartan ns11 ; taken from Fig. 1 , for comparison . The data from the hearts treated with losartan are Ž . Ž . Ž . Ž . indicated by I for SD hearts ns8 and`for the TGH hearts ns8 . AUCs are given in Table 2 . The data are given as mean"s.e.m. with the vertical lines indicating the errors.
( )at the end of the ischaemia but immediately before reperfu-Ž . sion were 16.1 " 6.5 mmHg SD; Fig. 3a and 36.9 " 6.2 Ž . mmHg TGH; Fig. 3b in the preconditioned hearts, while in the absence of preconditioning the corresponding values were significantly greater with values of 57.8 " 19.2 mmHg Ž . Ž . SD; P -0.05 and 81.4 " 6.7 mmHg TGH; P -0.001 . In all cases, there was a subsequent rise in EDP on Ž reperfusion, peaking at 5-15 min following reflow Fig.  .  3a,b .
In both the SD and TGH hearts, the AUC for the EDP-time plot between 0 and 60 min was significantly Ž . P-0.01 greater in the non-preconditioned than in the Ž . preconditioned state Fig. 3a,b; Table 2 .
Effects of losartan on end-diastolic pressure in the SD and TGH hearts
The presence of losartan did not influence the changes in EDP in the preconditioned SD hearts as the AUC for EDP was similar to that in the absence of the drug 0 -60 Ž . Fig. 3a ; Table 2 . But, in the TGH hearts, the presence of losartan partially reversed the beneficial effects of precon-
Ž . Fig. 3 . Changes in end-diastolic pressure following ischaemia and reperfusion in preconditioned and non-preconditioned a SD and b TGH hearts in the absence and presence of 3 mM losartan. The baseline end-diastolic pressures are prior to the 30 min of global ischaemia. R indicates reperfusion after the ischaemia and the time indicates the minutes after reflow. The data quoted at R are at the end of the ischaemic period and immediately before reperfusion and therefore represent the ischaemic contracture. B s data from the hearts subject to preconditioning; v s data from the non-preconditioned hearts;
I s data from preconditioned hearts obtained in the presence of losartan. AUCs are given in Table 2 . The data are given as mean"s.e.m. with the vertical lines indicating the errors. 
Ž value obtained in the absence of losartan Fig. 3b ; Table  . Ž . 2 . However, the value was still significantly P -0.01 less than in the non-preconditioned TGH hearts, such that, in the presence of losartan, diastolic function in the preconditioned, TGH hearts was intermediate between the preconditioned and the non-preconditioned hearts, in the absence of losartan.
Discussion
The findings of the present investigation clearly indicate that the protective effect of ischaemic cardiac preconditioning in TGH hearts is substantially upregulated. Furthermore, preconditioning in the TGH hearts also causes protection of diastolic function, which is partially sensitive to angiotensin, AT -receptor, blockade. 1 These important findings extend the work of Speechlyw x w x Dick et al. 12 and Boutros and Wang 13 who investigated the impact of cardiac preconditioning in steroid-induced hypertension and in SHRs, respectively. The findings from the present study confirm that hypertensive hearts can be preconditioned, but, more importantly, show for the first time that this process is substantially enhanced ŽŽ . . in hearts from mREN-2 27 transgenic rats. This supports the notion that preconditioning is not an 'all or nothing' process, and may be upregulated under certain circumstances.
The recovery of mechanical performance in the nonpreconditioned hearts was appreciably less than in the preconditioned preparations, confirming the efficacy of the preconditioning episodes. Importantly, in the non-preconditioned hearts, the recovery was similar in both TGH and SD groups, indicating that, in the absence of preconditioning, the TGH and SD hearts were equally susceptible to the deleterious effects of global ischaemia on reperfusion. Thus, the greater recovery of mechanical performance in the preconditioned TGH hearts, relative to the preconditioned SD hearts, must be attributable to an enhancement of preconditioning mechanisms. The effects were greatest in terms of LVDP, where there was a 3-fold difference in the magnitude of recovery between TGH and SD, while the difference was less marked for recovery of heart rate.
Hypertension in TGH rats is associated with various w x cardiovascular changes 14-17 . In the present study, cardiac mass to body mass ratio in the TGH hearts was increased, indicating cardiac hypertrophy, most probably of the left ventricle. Therefore, the effects of hypertension and cardiac hypertrophy on cardiac preconditioning cannot be dissociated in the TGH hearts. However, it should be noted that the degree of hypertrophy in the TGH hearts w x was substantially greater than in the DOCA-salt 12 and w x SHR 13 hearts in other studies. Therefore, it is possible that elevation of blood pressure or severity of hypertrophy must exceed a threshold before cardiac preconditioning is upregulated. There was, however, no direct correlation, within the preconditioned TGH group, between the degree Ž of cardiac hypertrophy and protection afforded data not . shown .
It was also found that, at equivalent flow rates, coronary perfusion pressure did not differ between the hypertensive and normotensive groups, which contrasts with the findw x ings of Kelm et al. 27 who reported a 30% higher coronary perfusion pressure in SHR hearts than in WistarKyoto controls. The present findings indicate that basal coronary vascular resistance was not elevated in the TGH hearts, perhaps due to adequate compensation by factors involved in the control of coronary resistance in isolated Ž w x w x. hearts e.g., nitric oxide 28 and K -channels 24 .
ATP
Hypertension in TGH rats is associated with enhanced w x local RAS activity in the heart 14,15,17,20 , which prompted the investigation using the selective angiotensin AT -receptor antagonist, losartan. This was of particular 1 relevance as angiotensin II, acting via protein kinase C activation, has been shown to mimic ischaemic precondiw x tioning 23 . In the TGH hearts, coronary perfusion pressure was not influenced by losartan, which rules out a role of basally released angiotensin II in the regulation of vascular tone. Addition of losartan did not influence recovery of mechanical performance in the preconditioned SD hearts, which indicates a lack of the involvement of endogenous angiotensin II in the cardioprotective properties of preconditioning on mechanical performance. Furthermore, losartan did not influence the enhanced effects of preconditioning on mechanical performance in the TGH hearts, which suggests that the intracardiac RAS does not mediate the augmented cardioprotection. This does not, however, exclude the cardiac RAS from playing a longerterm role in cardioprotection. The local RAS is involved in promoting cardiac hypertrophy in the rat in response to w x pressure overload 29 , and also in the TGH rat heart w x 20,21 . Furthermore, cardiac hypertrophy is accompanied w x by an increase in protein kinase C activity 30 which may w x be related to angiotensin II activity 31 . Therefore, in the context of cardiac preconditioning, an upregulation of protein kinase C, perhaps due to chronic cardiac RAS upregulation, may have important consequences as this second messenger system is thought to be a key mediator w x of the cardioprotective effects 6,7 .
An alternative explanation for the augmented preconditioning response seen in the TGH hearts could relate to metabolic differences, due to either hypertrophy or hypertension. Thus, there is evidence that in various rat models w x w x of cardiac hypertrophy 32,33 and hypertension 34 there is upregulation of, and increased dependence on, anaerobic glycolysis. Furthermore, enhanced glycolysis has been shown to promote recovery of mechanical performance on w x reperfusion following ischaemia 35 , by preserving highenergy phosphates during ischaemia by anaerobic metabolism of exogenous glucose. This preservation of ( )high-energy phosphates is thought to delay the onset of the deleterious effects of ischaemic damage through necrosis w x and mechanical dysfunction 36 . This may be particularly relevant to preconditioning as glycolysis is known to be w x enhanced by ischaemic preconditioning 36 . It is therefore possible that alterations in metabolic regulation in the Ž . TGH hearts e.g., increased glycolysis , may have made them more susceptible to cardioprotection by preconditioning.
Intraventricular pressure was found to increase in all cases during global ischaemia. This increase in pressure during ischaemia represents the ischaemic contracture and Ž . is associated with diastolic EDP impairment on reperfusion, due to alterations in intracellular metabolism and w x calcium handling 37 . In the present investigation, preconditioning greatly reduced the ischaemic contracture and the subsequent diastolic impairment, which accords with prew x vious findings in the rat heart 38,39 . These findings with the TGH and SD hearts suggest that preconditioning also exerts a protective effect on diastolic function, and that this protection does not differ between the preconditioned hearts from the hypertensive and normotensive groups. The Ž greater dysfunction as shown by the differences in the . AUCs for the EDP plots in the non-preconditioned TGH hearts, compared to the SD hearts, agrees with the findings in hypertrophied hearts, taken from rats with aortic coarctation, in which post-ischaemic diastolic dysfunction was greater than in normal hearts in the absence of precondiw x tioning 40 ; this was ascribed to calcium overload. In the case of the TGH hearts, the protective effect of preconditioning on diastolic function was partially sensitive to AT -receptor blockade, which was not the case in the SD 1 hearts. Thus, although the release of endogenous angiotensin II does not provide cardioprotection, it may be involved in the preservation of diastolic function in the TGH hearts.
In conclusion, the major finding of the present investigation is that hearts taken from hypertensive rats may be protected by cardiac preconditioning. Furthermore, in the TGH heart there is an enhancement of the effects of preconditioning, which may play an important role in limiting the deleterious effects of myocardial ischaemia. Part of the protective effect of preconditioning on diastolic function in TGH hearts would appear to be mediated via the local, intracardiac RAS.
